Technology Introduction:
Bertha is a 4nm AI prcocessor with LPDDR5x, designed for efficient Generative AI inference. Since infernece is bottlenecked by memory, Bertha has streamlined memory access and LLM-optimized compute dataflow to achieve 90% bandwidth utilization compared to GPU's 50%. It features highly scalable chip-to-chip networking to accelerate models of any scale. Bertha delivers 2x higher performance, 3x lower power consumption, and 10x better cost than GPUs.
Industry Applicability:
Bertha significantly reduces the total cost of ownership of cloud service providers when running Generative AI services and encourages wider adoption of AI in more diverse industries. Bertha is expected to replace the expensive GPUs from the datacenters for greater sustainability. Since Bertha is scalable, we also apply Bertha in edge computing to enable personalized AI in IoT devices and home appliances.
HyperAccel is a Republic of Korea (South Korea)-based fabless company developing AI chips to enable widespread deployment of Generative AI (GenAI). By targeting inference over training and focusing on LLMs instead of traditional AI models, HyperAccel is able to overcome cost barriers by designing the most efficient hardware solutions catered to GenAI. With their Bertha-Edge (BerthaE) AI chip designed to enable Generative and Agentic AI at the edge, HyperAccel was honored as one of the winners of the AI Core Technologies & Chips category in the IC Taiwan Grand Challenge (ICTGC) Batch 3.
12032925
12242564
12153898
12147746
“Collision free” control technology for group of robot vehicles applying fish schooling rules
Method and apparatus for extending local area network protocols to work across the internet and establishing connectivity without discovery for local area network protocols
“Collision free” control technology for group of robot vehicles applying fish schooling rules
Deception Based Cyber threat intelligence
技術成熟度:量產上市
展示目的:商機推廣
流通方式:新產品開發
*服務單位
*姓名
*電話
*您參觀這項展品的主要目的?
*您是否希望進一步洽談
*您的職務類別
*展覽整體評價
*最喜歡的展區
*期待展覽著重的技術領域
*是否願意收到電子報/最新資訊
其他建議
敬請期待!